Dr. Joseph V. Pergolizzi
My Social Links

Dr. Joseph V. Pergolizzi

Assistant Professor
Johns Hopkins University School of Medicine, USA

Highest Degree
M.D. in Medicine from Ross University School of Medicine, America

Share this Profile

Biography

Dr. Joseph V. Pergolizzi, Jr is an Adjunct Assistant Professor in the Department of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland, adjunct faculty member in the Department of Anesthesiology and Pain Medicine at Georgetown University School of Medicine in Washington, DC, and Associate Professor in the Department of Pharmacology at Temple University School of Medicine in Philadelphia, Pennsylvania. He has completed his M.D. in Medicine from Ross University School of Medicine, America, and Clinical Research Fellowship from The Johns Hopkins University School of Medicine Department of Medicine, Division of Endocrinology and Metabolism, Baltimore, M.D. He is also serving as member of editorial board and reviewer for number of journals. He is member of The American Chemical Society, AAAPNI, Hopkins Postdoctoral Association, Dr. Pergolizzi is a senior partner in the Naples Anesthesia and Pain Associates Group of Southwest Florida, and holds medical privileges at Physicians Day Surgery in Naples, Florida. He is Co-Founder and Chairman of the Board for the Association of Chronic Pain Patients, Dr. Pergolizzi is a member of the board of directors and treasurer for the Coalition for Pain Education (COPE), co-founder and Director of Research at the International Pain Research and Treatment Foundation, and a member of the board of directors of the National Institute of Pain, and Always Healthcare. He is the author of more than 135 peer-reviewed articles, abstracts, platform presentations and book chapters in his areas of interest and expertise.

Area of Interest:

Biomedical Sciences
100%
Anesthesia
62%
Opioids
90%
Pain
75%
Pharmacology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Pergolizzi, J.V., L. Ma, D.R. Foster, B.R. Overholser, K.M. Sowinski, R. Taylor and K.H. Summers, 2014. The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients. J. Manag. Care Spec. Pharm., 20: 467-476.
    PubMed  |  Direct Link  |  
  2. Pergolizzi, J.V. and J.A. LeQuang, 2014. Abuse-deterrent formulations of opioid analgesics. Pain Pract., 14: 204-206.
    CrossRef  |  Direct Link  |  
  3. Angeletti, C., C. Guetti, M.L. Ursini, R. Taylor and R. Papola et al., 2014. Low back pain in a natural disaster. Pain Pract., 14: E8-E16.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Taylor, R., J.V. Pergolizzi, F. Porreca and R.B. Raffa, 2013. Opioid antagonists for pain. Expert Opin. Invest. Drugs, 22: 517-525.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Taylor, R., J.V. Pergolizzi and R.B. Raffa, 2013. Tapentadol extended release for chronic pain patients. Adv Ther., 30: 14-27.
    CrossRef  |  PubMed  |  Direct Link  |  
  6. Taylor, R., J.V. Pergolizzi, A. Sinclair, R.B. Raffa, D. Aldington, S. Plavin and C.C. Apfel, 2013. Transversus abdominis block: clinical uses, side effects, and future perspectives. Pain Pract., 13: 332-344.
    CrossRef  |  PubMed  |  Direct Link  |  
  7. Raffa, R.B. and J.V. Pergolizzi, 2013. Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients? Pain Manage. Nursing, 14: e67-e83.
    CrossRef  |  Direct Link  |  
  8. Pergolizzi, J.V., S. Labhsetwar and J.A. LeQuang, 2013. Compounding pharmacies: who is in charge? Pain Pract., 13: 253-257.
    CrossRef  |  PubMed  |  Direct Link  |  
  9. Pergolizzi, J.V., R.B. Raffa, R. Taylor, G. Rodriguez, S. Nalamachu and P. Langley, 2013. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract., 13: 239-252.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Pergolizzi, J., R. BenJoseph, C.L. Chang, K. Pierz, D. Shah and G. Hess, 2013. Impact of dosage strength on medication persistence among patients treated with buprenorphine transdermal system. Value Health, 10.1016/j.jval.2013.03.576.
    CrossRef  |  Direct Link  |  
  11. Pergolizzi, J., K. Ahlbeck, D. Aldington, E. Alon and F. Coluzzi et al., 2013. The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment. Curr. Med. Res. Opin., 29: 1127-1135.
    CrossRef  |  Direct Link  |  
  12. Pergolizzi, J., G. Hess, C.L. Chang, D, Shah, K. Pierz and R. BenJoseph, 2013. Factors predicting medication persistence among patients initiating Buprenorphine transdermal system. Value Health, 10.1016/j.jval.2013.03.575.
    CrossRef  |  Direct Link  |  
  13. O'Brien, J., J.V. Pergolizzi, M. van de Laar, H.U. Mellinghoff and I.M. Merchante et al., 2013. Fixed-dose combinations at the front line of multimodal pain management: perspective of the nurse-prescriber. J. Nursing: Res. Rev., 3: 9-22.
    CrossRef  |  Direct Link  |  
  14. Merchante, I.M., J.V. Pergolizzi, M. van de Laar, H.U. Mellinghoff and S. Nalamachu et al., 2013. Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review. ISRN Family Med., 10.5402/2013/638469.
    CrossRef  |  Direct Link  |  
  15. Leslie, J.B., R.B. Raffa, R. Taylor, A. Tabor, E. Muniz, S. Nalamachu and J.V. Pergolizzi, 2013. Essential oxygen oil for treatment of sport-related injuries. Am. J. Sports Sci. Med., 1: 7-12.
    CrossRef  |  Direct Link  |  
  16. Yarlas, A., K. Miller, W. Wen, B. Dain and S.Y. Lynch et al., 2012. A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naive patients with moderate-to-severe chronic low back pain. J. Pain, 14: 14-23.
    CrossRef  |  PubMed  |  Direct Link  |  
  17. Van Laar, M., J.V. Pergolizzi Jr., H.U. Mellinghoff, I.M. Merchante and S. Nalamachu et al., 2012. Pain treatment in arthritis-related pain: Beyond NSAIDs. Open Rheumatol. J., 6: 320-330.
    CrossRef  |  PubMed  |  Direct Link  |  
  18. Taylor, R., S. Lemtouni, K. Weiss and J.V. Pergolizzi, 2012. Pain management in the elderly: An FDA safe use initiative expert panel's view on preventable harm associated with NSAID therapy. Curr. Gerontol. Geriatrics Res., Vol. 2012. 10.1155/2012/196159.
    CrossRef  |  
  19. Taylor, R., R.B. Raffa and J.V. Pergolizzi, 2012. Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature. J. Pain Res., 5: 77-87.
    CrossRef  |  PubMed  |  Direct Link  |  
  20. Raffa, R.B., R.J. Tallarida, R. Taylor and J.V. Pergolizzi, 2012. Fixed-dose combinations for emerging treatment of pain. Expert Opin. Pharmacother., 13: 1261-1270.
    CrossRef  |  PubMed  |  Direct Link  |  
  21. Raffa, R.B., J.V. Pergolizzi, E. Muniz, R. Taylor and J. Pergolizzi, 2012. Designing opioids that deter abuse. Pain Res. Treat., 10.1155/2012/282981.
    CrossRef  |  Direct Link  |  
  22. Raffa, R.B., J.J. Burmeister, E. Yuvasheva and J.V. Pergolizzi, 2012. QTc interval prolongation by d-propoxyphene: what about other analgesics? Expert Opin. Pharmacother., 13: 1397-1409.
    CrossRef  |  PubMed  |  Direct Link  |  
  23. Raffa, R.B. and J.V. Pergolizzi, 2012. Multi‐mechanistic analgesia for opioid‐induced hyperalgesia. J. Clin. Pharm. Therapeutics, 37: 125-127.
    CrossRef  |  
  24. Raffa, R.B. and J.V. Pergolizzi, 2012. Is morphine medicine's biggest misnomer? Ann. Pharmacother., 46: 1122-1123.
    CrossRef  |  PubMed  |  Direct Link  |  
  25. Raffa, R.B. and J.V. Pergolizzi Jr, 2012. The evolving understanding of the analgesic mechanism of action of flupirtine. J. Clin. Pharm. Therapeutics, 37: 4-6.
    CrossRef  |  
  26. Raffa, R.B. and J.V. Pergolizzi Jr, 2012. Intracerebroventricular opioids for intractable pain. Br. J. Clin. Pharmacol., 74: 34-41.
    CrossRef  |  Direct Link  |  
  27. Pergolizzi, V.J., M. van de Laar, R. Langford, H.U. Mellinghoff, I.M. Merchante, S. Nalamachu, J. O'Brien, S. Perrot and R.B. Raffa, 2012. Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain. J. Pain Res., 5: 327-346.
    CrossRef  |  Direct Link  |  
  28. Pergolizzi, J.V., R.B. Raffa, R. Taylor, S. Nagar, S. Labhsetwar, N. Sinclair and E.M. Gould, 2012. An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult. J. Opioid. Manag., 8: 383-393.
    CrossRef  |  PubMed  |  Direct Link  |  
  29. Pergolizzi, J.V., R.B. Raffa, R. Tallarida, R. Taylor and S.A. Labhsetwar, 2012. Continuous multimechanistic postoperative analgesia: A rationale for transitioning from intravenous acetaminophen and opioids to oral formulations. Pain Practice, 12: 159-173.
    CrossRef  |  
  30. Pergolizzi, J.V., R.B. Raffa, J.S. Pergolizzi and R. Taylor, 2012. Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse-deterrent formulations. Curr. Pharm. Des., 18: 6109-6115.
    CrossRef  |  PubMed  |  Direct Link  |  
  31. Pergolizzi, J.V., C. Gharibo, S. Passik, S. Labhsetwar, R. Taylor, J.S. Pergolizzi and G. Muller-Schwefe, 2012. Dynamic risk factors in the misuse of opioid analgesics. J. Psychosom. Res., 72: 443-451.
    CrossRef  |  PubMed  |  Direct Link  |  
  32. Pergolizzi, J.V., B.K. Philip, J.B. Leslie, R. Taylor and R.B. Raffa, 2012. Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting. J. Clin. Anesth., 24: 334-345.
    CrossRef  |  PubMed  |  Direct Link  |  
  33. Pergolizzi, J.V., 2012. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging, 29: 993-995.
    CrossRef  |  Direct Link  |  
  34. Pergolizzi, J., R. Raffa and R. Taylor, 2012. Low-dose transdermal buprenorphine system: An update. Paineurope, 1: 8-9.
  35. Pergolizzi, J., K. Ahlbeck, D. Aldington, E. Alon and B. Collett et al., 2012. The chronic pain conundrum: Should we CHANGE from relying on past history to assessing prognostic factors? Curr. Med. Res. Opin., 28: 249-256.
    CrossRef  |  
  36. Pergolizzi, J., C. Alegre, D. Blake, J.C. Alen and R. Caporali et al., 2012. Current considerations for the treatment of severe chronic pain: The potential for tapentadol. Pain Practice, 12: 290-306.
    CrossRef  |  Direct Link  |  
  37. Daitch, J., M.E. Frey, D. Silver, C. Mitnick, D. Daitch and J. Pergolizzi, 2012. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine. Pain Physician., 15: ES59-ES66.
    PubMed  |  Direct Link  |  
  38. Apfel, C.C., A. Turan, K. Souza, J. Pergolizzi and C. Hornuss, 2012. Intravenous acetaminophen reduces postoperative nausea and vomiting: a systematic review and meta-analysis. Pain, 154: 677-689.
    CrossRef  |  PubMed  |  Direct Link  |  
  39. Angeletti, C., C. Guetti, R. Papola, E. Petrucci and M.L. Ursini et al., 2012. Pain after earthquake. Scand. J. Trauma. Resusc. Emerg. Med., 10.1186/1757-7241-20-43.
    CrossRef  |  Direct Link  |  
  40. Varrassi, G., B. Collett, B. Morlion, E. Kalso and A. Nicolaou et al., 2011. Proceedings of the change pain expert summit in Rome, June 2010. Curr. Med. Res. Opin., 27: 2061-2062.
    CrossRef  |  Direct Link  |  
  41. Taylor, Jr. R., R.B. Raffa and J.V. Pergolizzi Jr, 2011. Naltrexone extended-release injection: An option for the management of opioid abuse. Substance Abuse Rehabilitation, 2: 219-226.
    CrossRef  |  Direct Link  |  
  42. Raffa, R.B. and J.V. Pergolizzi Jr, 2011. Deciphering the mechanism (s) of action of natural products: Analgesic peroxide oil as example. J. Clin. Pharm. Therapeutics, 36: 283-298.
    CrossRef  |  
  43. Pergolizzi, Jr. J.V., R. Taylor Jr and R.B. Raffa, 2011. Extended-release formulations of tramadol in the treatment of chronic pain. Expert Opinion Pharmacotherapy, 12: 1757-1768.
    CrossRef  |  
  44. Pergolizzi, J.V., T.J. Gan, S. Plavin, S. Labhsetwar and R. Taylor, 2011. Perspectives on the role of fospropofol in the monitored anesthesia care setting. Anesthesiol. Res. Practice, Vol. 2011. 10.1155/2011/458920.
    CrossRef  |  
  45. Pergolizzi, J.V., R. Raffa and R. Taylor, 2011. Prophylaxis of postoperative nausea and vomiting in adolescent patients: A review with emphasis on combination of fixed-dose ondansetron and transdermal scopolamine. J. Drug Delivery, Vol. 2011. 10.1155/2011/426813.
    CrossRef  |  
  46. Pergolizzi, J.V., 2011. Quantifying the impact of drug-drug interactions associated with opioids. Am. J. Managed Care, 17: S288-292.
    Direct Link  |  
  47. Pergolizzi, J., E. Alon, R. Baron, C. Bonezzi and J. Dobrogowski et al., 2011. Tapentadol in the management of chronic low back pain: A novel approach to a complex condition? J. Pain Res., 4: 203-210.
    CrossRef  |  
  48. Pergolizzi, J., 2011. In response: Urine drug screening and compliance. Pain Pract., 11: 199-199.
    CrossRef  |  
  49. Pergolizzi, J., 2011. Chronic pain-moving from symptom control to mechanism-based treatment. Curr. Med. Res. Opin., 27: 2079-2080.
    CrossRef  |  Direct Link  |  
  50. Pergolizzi, F., J. Pergolizzi, Z. Gan, S. Macario, J.V. Pergolizzi, T.J. Ewin and T.J. Gan, 2011. Bullying in middle school: Results from a 2008 survey. Int. J. Adolescent Med. Health, 23: 11-18.
  51. Pergolizzi Jr, J.V., S.A. Labhsetwar, R.A. Puenpatom, S. Joo, R.H. Ben‐Joseph and K.H. Summers, 2011. Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids. Pain Practice, 11: 230-239.
    CrossRef  |  
  52. Pergolizzi Jr, J.V., S.A. Labhsetwar, R.A. Puenpatom, S. Joo, R. Ben‐Joseph and K.H. Summers, 2011. Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: Incremental risk of multiple prescriptions. Pain Practice, 11: 325-336.
    Direct Link  |  
  53. Muller-Schwefe, G., W. Jaksch, B. Morlion, E. Kalso and M. Schafer et al., 2011. Make a CHANGE: Optimising communication and pain management decisions. Curr. Med. Res. Opin., 27: 481-488.
    CrossRef  |  
  54. Moore Simas, T.A., N. Byatt and K.M. Deligiannidis, 2011. Clinical roundup: How do you treat premenstrual syndrome in your practice? Alternat. Complement. Therapies, 17: 237-246.
  55. Melson, T., T. Chinachoit, A. Kett, K. Aqua and J. Levin et al., 2011. Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: A phase 3 study. Arch. Surg., 146: 201-206.
    CrossRef  |  
  56. Varrassi, G., G. Muller-Schwefe, J. Pergolizzi, A. Oronska and B. Morlion et al., 2010. Pharmacological treatment of chronic pain-the need for CHANGE. Curr. Med. Res. Opin., 26: 1231-1245.
    CrossRef  |  
  57. Singla, N.K., S.K. Singla, F. Chung, D.J. Kutsogiannis and L. Blackburn et al., 2010. Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients. Anesthesiology, 113: 74-82.
    Direct Link  |  
  58. Raffa, R.B., J.V. Pergolizzi, D.J. Segarnick and R.J. Tallarida, 2010. Oxycodone combinations for pain relief. Drugs Today, 46: 379-398.
    CrossRef  |  
  59. Raffa, R.B., J.V. Pergolizzi and R.J. Tallarida, 2010. The determination and application of fixed-dose analgesic combinations for treating multimodal pain. J. Pain, 11: 701-709.
    CrossRef  |  Direct Link  |  
  60. Raffa, R.B. and J.V. Pergolizzi Jr, 2010. Opioid formulations designed to resist/deter abuse. Drugs, 70: 1657-1675.
    CrossRef  |  
  61. Pergolizzi, J.V., M. Pappagallo, R.B. Raffa, C. Gharibo, R.B. Phillips, S. Desjonqueres and A. Tabor, 2010. Preliminary observations of a novel topical oil with analgesic properties for treatment of acute and chronic pain syndromes. Pain Practice, 10: 201-213.
    CrossRef  |  Direct Link  |  
  62. Pergolizzi, J., M. Pappagallo, J. Stauffer, C. Gharibo and N. Fortner et al., 2010. The role of urine drug testing for patients on opioid therapy. Pain Practice, 10: 497-507.
    CrossRef  |  
  63. Morlion, B., J.V. Pergolizzi and R.B. Raffa, 2010. European perspectives on upcoming analgesics: What do they have that we don't-and what do they think about them? Techniques Regional Anesthesia Pain Manage., 14: 86-98.
    CrossRef  |  Direct Link  |  
  64. Leslie, J.B., E.R. Viscusi, J.V. Pergolizzi and S.J. Panchal, 2010. Anesthetic routines: The anesthesiologist's role in GI recovery and postoperative ileus. Adv. Preventive Med., Vol. 2011. 10.4061/2011/976904.
    CrossRef  |  
  65. Langley, P., G. Muller-Schwefe, A. Nicolaou, H. Liedgens, J. Pergolizzi and G. Varrassi, 2010. The societal impact of pain in the European Union: Health-related quality of life and healthcare resource utilization. J. Med. Econ., 13: 571-581.
    CrossRef  |  
  66. Langley, P., G. Muller-Schwefe, A. Nicolaou, H. Liedgens, J. Pergolizzi and G. Varrassi, 2010. The impact of pain on labor force participation, absenteeism and presenteeism in the European Union. J. Med. Econ., 13: 662-672.
    CrossRef  |  Direct Link  |  
  67. Hochman, J.S. and J. Pergolizzi, 2010. Cohort study finds nine times increased overdose risk (fatal plus non-fatal) in patients receiving 100 mg/day for 90 days compared with 1-20 mg/day opioids for chronic non-cancer pain, but wide CI and possibility of unmeasured confounders. Evidence Based Nursing, 13: 55-56.
    CrossRef  |  
  68. Arbuck, D., C. Gharibo, S. Labhsetwar, F. Berdos and J. Pergolizzi, 2010. Management of opioid tolerability and related adverse effects. J. Med., 3: 1-10.
  69. Apfel, C.C., O.S. Cakmakkaya, W. Martin, C. Richmond and A. Macario et al., 2010. Restoration of disk height through non-surgical spinal decompression is associated with decreased discogenic low back pain: A retrospective cohort study. BMC Musculoskeletal Disorders, Vol. 11. 10.1186/1471-2474-11-155.
    CrossRef  |  
  70. Apfel, C.C., K. Zhang, E. George, S. Shi and L. Jalota et al., 2010. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: A systematic review and meta-analysis. Clin. Therapeutics, 32: 1987-2002.
    CrossRef  |  Direct Link  |  
  71. Sinclair, A., J. Pergolizzi and C. Richmond, 2009. Patients who smoke: To cut or not to cut. J. Med., 2: 56-61.
  72. Pergolizzi, Jr. J.V., S. Mercadante, A.V. Echaburu, B.V.D. Eynden and R.M.D.F. Fragoso et al., 2009. The role of transdermal buprenorphine in the treatment of cancer pain: An expert panel consensus. Curr. Med. Res. Opinion, 25: 1517-1528.
    CrossRef  |  
  73. Pergolizzi, Jr. J.V., R.B. Raffa and E. Gould, 2009. Considerations on the use of oxymorphone in geriatric patients. Expert Opin. Drug Saf., 8: 603-613.
    CrossRef  |  
  74. Pergolizzi, Jr. J.V. and R.B. Raffa, 2009. Oxymorphone and opioid rotation. Pain Med., 10: S39-S48.
    CrossRef  |  Direct Link  |  
  75. Pergolizzi, J., L. Claybon, A. Macario and C. Richmond, 2009. Therapeutic decision support and the management of post operative nausea and vomiting. J. Med., 2: 62-67.
  76. Pergolizzi, J. and R. Raffa, 2009. The use of high-dose transdermal buprenorphine in the treatment of cancer pain. J. Med., 2: 111-120.
  77. Pergolizzi, F., D. Richmond, G. Zoe, S. Macario and A. Macario et al., 2009. Two-year survey of bullying in American middle schools. J. Med., 2: 45-61.
  78. Groteke, E., J. Pergolizzi and D. Chicoine, 2009. The quantification and tracking of osteoarthritis. J. Med., 2: 23-29.
  79. Gan, T.J., A.C. Sinha, A.L. Kovac, R.K. Jones and S.A. Cohen et al., 2009. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesthesia Analgesia, 108: 1498-1504.
    CrossRef  |  
  80. Pergolizzi, J., T. Yochum and F. Florio, 2008. Management of discogenic low-back pain with a non-surgical decompression system (DRX9000TM)-Case Report. US Musculoskeletal Rev., 1: 14-15.
  81. Pergolizzi, J., F. Florio and W. Martin, 2008. Management of low-back pain with a non-surgical spinal decompression system (DRX9000TM)-case report. Eur. Musculoskeletal Rev., 1: 59-60.
  82. Pergolizzi, J., C. Richmond, M. Auster, F. Florio and J. Wilhelm, 2008. Non-surgical spinal decompression (DRX9000TM) for the treatment of chronic low back pain-case report. Eur. Musculoskeletal Rev., 3: 58-60.
  83. Macario, A., C. Richmond, M. Auster and J.V. Pergolizzi, 2008. Treatment of 94 outpatients with chronic discogenic low back pain with the DRX9000: A retrospective chart review. Pain Pract., 8: 11-17.
    CrossRef  |  
  84. Davis, M., V. Maida, P. Daeninck and J. Pergolizzi, 2007. The emerging role of cannabinoid neuromodulators in symptom management. Supportive Care Cancer, 15: 63-71.
    CrossRef  |  Direct Link  |  
  85. Pergolizzi, J., 2006. Are there any effective strategies for managing opioid-induced bowel dysfunction (OBD). RSDSA Rev., 19: 8-8.
  86. Macario, A., L. Claybon and J.V. Pergolizzi, 2006. Anesthesiologists' practice patterns for treatment of postoperative nausea and vomiting in the ambulatory Post Anesthesia Care Unit. BMC Anesthesiol., Vol. 6. 10.1186/1471-2253-6-6.
    CrossRef  |  
  87. Macario, A. and J.V. Pergolizzi, 2006. Systematic literature review of spinal decompression via motorized traction for chronic discogenic low back pain. Pain Practice, 6: 171-178.
    CrossRef  |  Direct Link  |  
  88. Pergolizzi, J., 2005. New rules for scientific experts with industry ties. Clin. Res., 2005: 4-5.
  89. Pergolizzi, J., 2005. Improper informed consent practices in India: A wake-up call to rethink the process. Clin. Res., 5: 4-5.
  90. Macario, A. and J.V. Pergolizzi Jr, 2005. Urine drug testing in chronic pain patients taking opioids: A clinical practice update. Int. J. Pain Med. Palliative Care, 4: 133-139.
  91. Pergolizzi, J., 2004. Tightening up the nutraceuticals market: The need for competent and reliable scientific evidence. Clin. Res., 4: 4-5.
  92. Macario, A. and J. Pergolizzi, 2004. Pain and nausea management after surgery. Int. J. Pain Palliative Care, 3: 91-100.
  93. Pergolizzi, J., 2003. To test or not to test: Clinical trials in pediatrics. Clin. Res., 3: 4-5.
  94. Pergolizzi, J., 2003. The bioterrorism act: Necessary risk. Clin. Res., 3: 4-5.
  95. Pergolizzi, J., 2003. Skin in the game. Clin. Res., 3: 4-5.
  96. Pergolizzi, J., 2003. Ownership, access, and publication: Take two. Clin. Res., 3: 4-5.
  97. Pergolizzi, J., 2003. A taste of things to come. Clin. Res., 3: 4-5.
  98. Pergolizzi, J., 2002. The study monitor: Cooperative troubleshooter Clin. Res., 2: 4-5.
  99. Pergolizzi, J., 2002. Standing out from the crowd. Clin. Res., 2: 4-5.
  100. Pergolizzi, J., 2002. Publish or perish: Whose right is it? Clin. Res., 2: 4-5.
  101. Pergolizzi, J., 2002. Pipelines: Strength in depth. Clin. Res., 2: 4-5.
  102. Pergolizzi, J., 2002. Networking: Getting and staying connected. Clin. Res., 2: 4-5.
  103. Pergolizzi, J., 2002. In the public eye. Clin. Res., 2: 4-5.
  104. Pergolizzi, J., 2002. Early termination: Conflicts and concerns. Clin. Res., 5: 4-5.
  105. Pergolizzi, J., 2002. Addressing the learning curve. Clin. Res., 2: 4-5.
  106. Pergolizzi, J., 2001. The information web - surfers beware. Clin. Res., 1: 4-5.
  107. Pergolizzi, J., 2001. The changing role of the modern coordinator. Clin. Res., 1: 4-5.
  108. Pergolizzi, J., 2001. Peripheral learning: Pearls of wisdom. Clin. Res., 1: 4-5.
  109. Pergolizzi, J., 2001. IRB Accreditation: A conformity assessment. Clin. Res., 1: 4-5.
  110. Pergolizzi, J., 2001. Diversity brings depth. Clin. Res., 1: 4-5.
  111. Pergolizzi, J., 2001. Clinical trials on the street. Clin. Res., 1: 4-5.
  112. Pergolizzi, J., 2001. Chasing the bid. Clin. Res., 1: 4-5.
  113. Pergolizzi, J., 2001. A salute to all volunteers. Clin. Res., 1: 4-5.
  114. Ashkenazy, R., J. Pergolizzi and A. Dobs, 2001. Organizational model for a clinical trials unit within an academic medical center. Res. Practitioner, 2: 107-112.